Medicale Corp. (MCLE) EBIT (2020 - 2025)
Medicale's (MCLE) quarterly EBIT came in at -$3144.0 in Q4 2025, up 79.03% YoY from -$1756.1 in Q4 2024, and up 63.67% on a QoQ basis from -$8654.0 in Q3 2025.
Medicale Corp. (MCLE) EBIT (2020 - 2025) Analysis & Trends
Medicale (MCLE) has 6 years of EBIT data on file, last reported at -$3144.0 in Q4 2025.
- Quarterly EBIT rose 79.03% year-over-year to -$3144.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$21642.0 (up 57.06% YoY) and the FY2025 annual result came in at -$33493.0, up 38.78% from the prior year.
- EBIT grew to -$3144.0 in Q4 2025, from -$8654.0 in the prior quarter.
- In the past five years, EBIT ranged from a high of -$3144.0 in Q4 2025 to a low of -$19307.0 in Q4 2023.
- A 5-year average of -$9679.7 and a median of -$8595.5 in 2023 frame the typical range for EBIT.
- Annual changes were most pronounced in 2023 — EBIT sank 121.56% — and 2025, when it jumped 79.03%.
- Tracing MCLE's EBIT over 5 years: stood at -$18096.0 in 2021, then surged by 51.85% to -$8714.0 in 2022, then plunged by 121.56% to -$19307.0 in 2023, then grew by 22.33% to -$14995.0 in 2024, then jumped by 79.03% to -$3144.0 in 2025.
- The last three EBIT figures came in at -$3144.0 (Q4 2025), -$8654.0 (Q3 2025), and -$3575.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3,144.00 |
| Sep 30, 2025 | -8,654.00 |
| Jun 30, 2025 | -3,575.00 |
| Mar 31, 2025 | -6,269.00 |
| Dec 31, 2024 | -14,995.00 |
| Sep 30, 2024 | -15,509.00 |
| Jun 30, 2024 | -9,288.00 |
| Mar 31, 2024 | -10,603.00 |
| Dec 31, 2023 | -19,307.00 |
| Sep 30, 2023 | -14,227.00 |
| Jun 30, 2023 | -8,537.00 |
| Mar 31, 2023 | -6,115.00 |
| Dec 31, 2022 | -8,714.00 |
| Sep 30, 2022 | -13,754.00 |
| Jun 30, 2022 | -6,134.00 |
| Mar 31, 2022 | -6,035.00 |
| Dec 31, 2021 | -18,096.00 |
| Sep 30, 2021 | -6,547.00 |
| Jun 30, 2021 | -6,916.00 |
| Mar 31, 2021 | -7,175.00 |